FI894566A0 - Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents
Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar.Info
- Publication number
- FI894566A0 FI894566A0 FI894566A FI894566A FI894566A0 FI 894566 A0 FI894566 A0 FI 894566A0 FI 894566 A FI894566 A FI 894566A FI 894566 A FI894566 A FI 894566A FI 894566 A0 FI894566 A0 FI 894566A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutiska
- benzazepiner
- blandningar
- substituerade
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3213587A | 1987-03-27 | 1987-03-27 | |
| PCT/US1988/000899 WO1988007526A1 (en) | 1987-03-27 | 1988-03-24 | Substituted benzazepines, their preparation and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI894566A FI894566A (fi) | 1989-09-27 |
| FI894566A0 true FI894566A0 (fi) | 1989-09-27 |
Family
ID=21863286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI894566A FI894566A0 (fi) | 1987-03-27 | 1989-09-27 | Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar. |
Country Status (18)
| Country | Link |
|---|---|
| EP (2) | EP0357641A1 (ko) |
| JP (1) | JPH0662574B2 (ko) |
| KR (1) | KR930011489B1 (ko) |
| AT (1) | ATE112766T1 (ko) |
| AU (1) | AU619744B2 (ko) |
| CA (1) | CA1321195C (ko) |
| DE (1) | DE3851769T2 (ko) |
| DK (1) | DK165688C (ko) |
| FI (1) | FI894566A0 (ko) |
| HU (1) | HU205744B (ko) |
| IL (1) | IL85855A (ko) |
| MY (1) | MY103357A (ko) |
| NO (1) | NO174507B (ko) |
| NZ (1) | NZ224038A (ko) |
| PH (1) | PH27337A (ko) |
| PT (1) | PT87068B (ko) |
| WO (1) | WO1988007526A1 (ko) |
| ZA (1) | ZA882080B (ko) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK107688D0 (da) * | 1988-03-01 | 1988-03-01 | Novo Industri As | Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner |
| DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
| US5068326A (en) * | 1989-04-03 | 1991-11-26 | Kung Hank F | Dopamine receptor ligands and imaging agents |
| WO1991019698A1 (en) * | 1990-06-15 | 1991-12-26 | Schering Corporation | 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substitued benzazepines and pharmaceutical compositions containing them |
| AU8536591A (en) * | 1990-09-25 | 1992-04-15 | Schering Corporation | Peri-condensed benzazepines |
| US5241065A (en) * | 1992-02-25 | 1993-08-31 | Schering Corporation | 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity |
| ATE305454T1 (de) * | 2000-07-05 | 2005-10-15 | Ortho Mcneil Pharm Inc | Nichtpeptidische substituierte spirobenzoazepine als vasopressin antagonisten |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| BR0317483A (pt) * | 2002-12-20 | 2005-11-16 | Glaxo Group Ltd | Derivados de benzodiazepina para o tratamento de desordens neurológicas |
| JP2006526021A (ja) | 2003-05-22 | 2006-11-16 | シェーリング コーポレイション | 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体 |
| AU2012200805B2 (en) * | 2003-06-17 | 2015-01-22 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| HUE028976T2 (en) | 2003-06-17 | 2017-02-28 | Arena Pharm Inc | 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| CN1805939B (zh) * | 2003-06-17 | 2010-10-13 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物 |
| US20070275949A1 (en) * | 2003-10-22 | 2007-11-29 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases |
| WO2005042491A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| DK1838677T3 (da) | 2004-12-21 | 2010-01-11 | Arena Pharm Inc | Krystallinske former af (R)-8-chlor-1.methyl-2,3,4,5-tetrahydro-1H-3-benzazepinhydrochlorid |
| SI1833473T1 (sl) | 2004-12-23 | 2010-01-29 | Arena Pharm Inc | Sestavki modulatorjev 5HT2C receptorjev in postopki uporabe |
| JP5199997B2 (ja) | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス |
| SG177128A1 (en) | 2006-12-05 | 2012-01-30 | Arena Pharm Inc | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| US8822727B2 (en) | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| EP2443080A2 (en) | 2009-06-18 | 2012-04-25 | Arena Pharmaceuticals, Inc. | Process for the preparation of 5-ht2c receptor agonists |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| CN103347523A (zh) | 2010-09-01 | 2013-10-09 | 艾尼纳制药公司 | 向具有肾损伤的个体给药氯卡色林 |
| EP2611782A1 (en) | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
| EP3485878A1 (en) | 2010-09-01 | 2019-05-22 | Arena Pharmaceuticals, Inc. | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| CA2808904A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
| MY181736A (en) | 2012-10-09 | 2021-01-05 | Arena Pharm Inc | Method of weight management |
| HU230826B1 (hu) | 2014-11-19 | 2018-07-30 | Richter Gedeon Nyrt. | Eljárás benzazepin származékok előállítására |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA974989A (en) * | 1968-03-11 | 1975-09-23 | Wallace And Tiernan Inc. | Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby |
| DE1934150A1 (de) * | 1968-07-10 | 1970-01-15 | Pennwalt Corp | Neue 1-Alkanoyloxy-1,2,4,5-tetrahydro-3H,3-benzazepine |
| US4988690A (en) * | 1982-06-14 | 1991-01-29 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof |
| DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
| US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
| GB8807922D0 (en) * | 1988-04-05 | 1988-05-05 | Fujisawa Pharmaceutical Co | Isoquinoline compound & process for preparation thereof |
-
1988
- 1988-03-23 ZA ZA882080A patent/ZA882080B/xx unknown
- 1988-03-23 PH PH36675A patent/PH27337A/en unknown
- 1988-03-24 EP EP88903596A patent/EP0357641A1/en active Pending
- 1988-03-24 MY MYPI88000305A patent/MY103357A/en unknown
- 1988-03-24 HU HU882812A patent/HU205744B/hu not_active IP Right Cessation
- 1988-03-24 CA CA000562352A patent/CA1321195C/en not_active Expired - Fee Related
- 1988-03-24 AU AU15964/88A patent/AU619744B2/en not_active Ceased
- 1988-03-24 IL IL85855A patent/IL85855A/xx not_active IP Right Cessation
- 1988-03-24 KR KR1019880701534A patent/KR930011489B1/ko not_active IP Right Cessation
- 1988-03-24 AT AT88104758T patent/ATE112766T1/de not_active IP Right Cessation
- 1988-03-24 JP JP63503399A patent/JPH0662574B2/ja not_active Expired - Lifetime
- 1988-03-24 WO PCT/US1988/000899 patent/WO1988007526A1/en not_active Application Discontinuation
- 1988-03-24 PT PT87068A patent/PT87068B/pt not_active IP Right Cessation
- 1988-03-24 DE DE3851769T patent/DE3851769T2/de not_active Expired - Fee Related
- 1988-03-24 EP EP88104758A patent/EP0285919B1/en not_active Expired - Lifetime
- 1988-03-25 NZ NZ224038A patent/NZ224038A/xx unknown
- 1988-11-15 NO NO885096A patent/NO174507B/no unknown
- 1988-11-23 DK DK652688A patent/DK165688C/da active
-
1989
- 1989-09-27 FI FI894566A patent/FI894566A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1988007526A1 (en) | 1988-10-06 |
| HU205744B (en) | 1992-06-29 |
| ZA882080B (en) | 1989-04-26 |
| MY103357A (en) | 1993-06-30 |
| DK652688D0 (da) | 1988-11-23 |
| NO174507B (no) | 1994-02-07 |
| PT87068B (pt) | 1992-07-31 |
| NZ224038A (en) | 1990-10-26 |
| NO885096L (no) | 1988-11-15 |
| KR930011489B1 (ko) | 1993-12-08 |
| KR890700577A (ko) | 1989-04-25 |
| EP0285919B1 (en) | 1994-10-12 |
| DE3851769D1 (de) | 1994-11-17 |
| FI894566A (fi) | 1989-09-27 |
| DK165688B (da) | 1993-01-04 |
| IL85855A0 (en) | 1988-09-30 |
| NO174507C (ko) | 1994-05-18 |
| EP0357641A1 (en) | 1990-03-14 |
| HUT53882A (en) | 1990-12-28 |
| DE3851769T2 (de) | 1995-03-09 |
| ATE112766T1 (de) | 1994-10-15 |
| IL85855A (en) | 1993-02-21 |
| NO885096D0 (no) | 1988-11-15 |
| PT87068A (pt) | 1988-04-01 |
| DK165688C (da) | 1993-05-24 |
| EP0285919A1 (en) | 1988-10-12 |
| CA1321195C (en) | 1993-08-10 |
| PH27337A (en) | 1993-06-08 |
| JPH0662574B2 (ja) | 1994-08-17 |
| JPH02502723A (ja) | 1990-08-30 |
| AU619744B2 (en) | 1992-02-06 |
| AU1596488A (en) | 1988-11-02 |
| DK652688A (da) | 1988-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI894566A0 (fi) | Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| PH23607A (en) | Amide derivatives and pharmaceutical composition containing said compounds | |
| DE69332577D1 (de) | Verfahren zur Herstellung von 13-Ether-Derivaten von Milbemycinen und Zwischenprodukte | |
| DE69326395D1 (de) | Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms | |
| AU1832988A (en) | Thiazole derivatives | |
| EP1147772A4 (en) | DRUG COMPOSITIONS FOR THE TREATMENT OF EAR FIBRILLATION | |
| GB2207917B (en) | Insecticidal tetrafluorobenzyl esters characterised by enhanced knockdown effect | |
| ATE100077T1 (de) | 2-hydroxy-3-phenoxypropylaminoverbindungen. | |
| HUT54277A (en) | Fungicidal compositions comprising 3-(methoxyimino)-propionic acid esters as active ingredient and process for producing the active ingredients | |
| FR2377382A1 (fr) | Nouveaux phenylazacycloalcanes utiles comme medicaments | |
| DE69309461D1 (de) | Zusammensetzung zur Beschleunigung der Wundheilung | |
| DE69107561D1 (de) | Verfahren zur Herstellung von 4-Methylsulfonylbenzoesäurederivate und Zwischenprodukte. | |
| PL264320A1 (en) | A fungicide and a method of active matter production | |
| GR3026397T3 (en) | Para-hydroxyaniline derivatives, process for their preparation and their use as fungicides or pesticides. | |
| HUT54688A (en) | Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components | |
| ATE30911T1 (de) | Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ES2044883T3 (es) | Procedimiento para preparar quinoxalinas sustituidas. | |
| ES8307831A1 (es) | Procedimiento para preparar nuevos derivados organofosfora- dos. | |
| MY103596A (en) | Insecticidal compounds - characterised by enhanced knockdown effect. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed | ||
| FD | Application lapsed |
Owner name: SCHERING CORPORATION |